{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:43:18Z","timestamp":1790638998677,"version":"4.1.0"},"reference-count":21,"publisher":"BMJ","funder":[{"name":"Vision Health Research Network (VHRN) from the Fonds de recherche du Qu\u00e9bec \u2013 Sant\u00e9"},{"name":"Fonds de recherche du Centre universitaire d\u2019ophtalmologie du CHU de Qu\u00e9bec"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,8,16]]},"abstract":"<jats:p>We present the case of a 56-year-old man who developed a neoplasm of epithelioid histology in his anophthalmic left orbit 21 years after he underwent enucleation for a spindle cell iris melanoma. The recurrent tumour was managed by orbital exenteration. Neither further recurrence nor metastasis was diagnosed over a 5-year follow-up period. This case, along with five other similar cases in the literature,<jats:sup>1\u20133<\/jats:sup>emphasises the importance of long-term follow-up after treatment of iris melanoma.<\/jats:p>","DOI":"10.1136\/bcr-2017-221137","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T19:22:52Z","timestamp":1504812172000},"page":"bcr-2017-221137","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Orbital recurrence of iris melanoma 21 years after enucleation"],"prefix":"10.1136","volume":"2017","author":[{"given":"Emilie","family":"Bergeron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Lihimdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Landreville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,9,7]]},"reference":[{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.1","first-page":"458","article-title":"Malignant melanoma of the iris after 30 years","volume":"15 62","author":"Montgomery","year":"1983","journal-title":"Ann Ophthalmol"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.2","first-page":"720","article-title":"Malignant melanoma of the iris: recurrence after 19 years","volume":"17","author":"Roth","year":"1985","journal-title":"Ann Ophthalmol"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.3","doi-asserted-by":"crossref","unstructured":"Fabian ID , Thaung C , AlHarby L , et al . Late solitary extraocular recurrence from previously resected Iris Melanoma. Am J Ophthalmol 2017:97\u2013105.doi:10.1016\/j.ajo.2017.06.025","DOI":"10.1016\/j.ajo.2017.06.025"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3747\/co.23.2859","article-title":"Management of uveal melanoma: a consensus-based provincial clinical practice guideline","volume":"23","author":"Weis","year":"2016","journal-title":"Curr Oncol"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.5","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/IAE.0b013e31824d09a8","article-title":"Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases","volume":"32","author":"Shields","year":"2012","journal-title":"Retina"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.survophthal.2016.12.012","article-title":"Radiotherapeutic and surgical management of iris melanoma: A review","volume":"62","author":"Popovic","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4274\/tjo.37431","article-title":"Uveal Melanoma: current trends in diagnosis and management","volume":"46","author":"Tarlan","year":"2016","journal-title":"Turk J Ophthalmol"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.11.004"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(91)32298-X"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.10","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.79.4.306"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.11","unstructured":"Edge SB , Byrd DR , Compton CC , et al . AJCC Cancer Staging Manual. 7th ed. \u00a0New York, NY: Springer, 2009:547\u201359."},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.12","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0440"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.13","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.286"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamaophthalmol.2015.3200","article-title":"A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations","volume":"133","author":"Larsen","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.15","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-308301"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.09.014"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.17","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.208"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00449-8"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1755-3768.2010.01889.x","article-title":"Surgical treatment of iris and ciliary body melanoma: follow-up of a 25-year series of patients","volume":"90","author":"Klauber","year":"2012","journal-title":"Acta Ophthalmol"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/573974","article-title":"Uveal melanoma","volume":"2011","author":"Papastefanou","year":"2011","journal-title":"J Skin Cancer"},{"key":"2025042712373632000_2017.sep07_2.bcr-2017-221137.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00182-2"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-221137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T19:37:45Z","timestamp":1745782665000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-221137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,7]]},"references-count":21,"alternative-id":["10.1136\/bcr-2017-221137"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-221137","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,7]]}}}